# Phase 2 Bunionectomy HTX-011 Administration Study

> **NCT03718039** · PHASE2 · COMPLETED · sponsor: **Heron Therapeutics** · enrollment: 78 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** HTX-011
- **DEVICE:** Luer Lock applicator
- **DEVICE:** Vial access device
- **DRUG:** aprepitant

## Key facts

- **NCT ID:** NCT03718039
- **Lead sponsor:** Heron Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-24
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-03-11
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718039, "Phase 2 Bunionectomy HTX-011 Administration Study". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT03718039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*